Abstract Details
|
Antonino Giordano
(San Raffaele Scientific Institute)
PRESENTER |
Mr. Giordano has nothing to disclose. |
| Maria Needhamsen | No disclosure on file |
| Klementy Shchetynsky (Karolinska Institutet) | No disclosure on file |
| Pernilla Stridh (Karolinska Institutet) | No disclosure on file |
| Adil Harroud, MD (McGill University) | Dr. Harroud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Harroud has received research support from National Multiple Sclerosis Society. The institution of Dr. Harroud has received research support from Multiple Sclerosis Society of Canada. |
| Christiane Gasperi | No disclosure on file |
| Iaroslav Zinevych | No disclosure on file |
| Kimmo Pääkkönen | No disclosure on file |
| Päivi Lahermo (University of Helsinki) | No disclosure on file |
| Sandra D'Alfonso | No disclosure on file |
| Nadia Barizzone (University of Eastern Piedmont) | No disclosure on file |
| Paola Cavalla | No disclosure on file |
| Antonio Gallo | Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. |
| Elena Chinni (I.R.C.C.S Casa Sollievo della Sofferenza) | No disclosure on file |
| Bernhard Hemmer | No disclosure on file |
| Martina Flaskamp | No disclosure on file |
| Paula Uibel | No disclosure on file |
| Fredrik L. Piehl, MD, PhD (Neuroimmunology Unit, Dept Clinical Neuroscience, Karolinska Institutet) | Dr. Piehl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parexel/Chugai. The institution of Dr. Piehl has received research support from UCB. The institution of Dr. Piehl has received research support from Merck KGaA. Dr. Piehl has received personal compensation in the range of $10,000-$49,999 for serving as a member scientific advisory board with Swedish Medical products Agency. |
| Federica Esposito | Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Federica Esposito has received research support from Italian MS Society. The institution of Federica Esposito has received research support from Italian Ministry of Health. The institution of Federica Esposito has received research support from ERA Net. The institution of Federica Esposito has received research support from European Commission. Federica Esposito has received intellectual property interests from a discovery or technology relating to health care. |
| Elisabetta Mascia | No disclosure on file |
| Melissa Sorosina | No disclosure on file |
| Massimo Filippi, MD, FAAN (Ospedale San Raffaele, Neuroimaging Research Unit) | Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. |
| Stefan Gustavsen (Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University) | No disclosure on file |
| Anna Olsson | No disclosure on file |
| Helle B. Sondergaard, PhD (Danish MS Center, University Hospital Rigshospitalet) | Dr. Sondergaard has nothing to disclose. |
| Annette Bang Oturai, MD | Dr. Oturai has nothing to disclose. |
| Benedicte Dubois (UZ Leuven) | No disclosure on file |
| Hanne H (Faculty of Medicine, University of Oslo) | No disclosure on file |
| Tone Berge | No disclosure on file |
| Steffan Bos | No disclosure on file |
| Pablo Villoslada, MD, PhD, FAAN (Hospital del Mar Research Institute) | Dr. Villoslada has received personal compensation for serving as an employee of Attune Neuroscience. Dr. Villoslada has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Accure Therapeutics. Dr. Villoslada has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculis. Dr. Villoslada has stock in Attune Neurosciences. Dr. Villoslada has stock in Bionure Investments. Dr. Villoslada has stock in Spiral Therapeutics. Dr. Villoslada has stock in Adhera Health. The institution of Dr. Villoslada has received research support from Start2Cure Foundation. The institution of Dr. Villoslada has received research support from NIH. The institution of Dr. Villoslada has received research support from Department of Defense. Dr. Villoslada has received intellectual property interests from a discovery or technology relating to health care. |
| Sara Llufriu | Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merci. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbot. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. |
| Filippo Martinelli Boneschi | No disclosure on file |
| Roland Liblau | Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-genzyme. Roland Liblau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Servier. Roland Liblau has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Opinion in Immunology. The institution of Roland Liblau has received research support from Roche. The institution of Roland Liblau has received research support from ARSEP. The institution of Roland Liblau has received research support from Fondation pour la Recherche Médicale. The institution of Roland Liblau has received research support from Population Bio UK, Inc. The institution of Roland Liblau has received research support from ANR. |
| Beatrice Pignolet | Beatrice Pignolet has nothing to disclose. |
| Ingrid Kockum | No disclosure on file |
| Stephan Beck (UCL) | No disclosure on file |
| Janna Saarela (Institute for Molecular Medicine Finland, University of Helsinki) | No disclosure on file |
| Maja Jagodic (Karolinska Institutet) | No disclosure on file |